Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-01-24 Option Award |
2024-02-07 4:43 pm |
N/A 2034-01-24 |
GALECTIN THERAPEUTICS INC | GALT | Boudes Pol F Chief Medical Officer |
105,000 | $0 | 105,000 (Direct) |
View |
2023-09-29 Option Award |
2023-10-03 5:00 pm |
N/A 2033-09-29 |
Protalix BioTherapeutics Inc. | PLX | Boudes Pol F Director |
61,676 | $0 | 61,676 (Direct) |
View |
2023-01-26 Option Award |
2023-01-30 4:37 pm |
N/A 2033-01-26 |
GALECTIN THERAPEUTICS INC | GALT | Boudes Pol F Chief Medical Officer |
50,000 | $0 | 50,000 (Direct) |
View |
2022-09-07 Option Award |
2022-09-09 5:00 pm |
N/A 2032-09-07 |
Protalix BioTherapeutics Inc. | PLX | Boudes Pol F Director |
50,000 | $0 | 50,000 (Direct) |
View |
2022-01-24 Option Award |
2022-01-25 4:17 pm |
N/A 2032-01-24 |
GALECTIN THERAPEUTICS INC | GALT | Boudes Pol F Chief Medical Officer |
50,000 | $0 | 50,000 (Direct) |
View |
2021-03-25 Option Award |
2021-03-29 4:35 pm |
N/A 2031-03-25 |
GALECTIN THERAPEUTICS INC | GALT | Boudes Pol F Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |